To this regard, Michael Quinn presented results about TNFRII+ Treg, which express higher levels of FoxP3 than conventional Treg, express CCR4 (migration to tumor) and CCR7 (migration to lymph nodes -interferes with priming of anti-tumor responses). Here, FOXP3 is linked to neoplasm.